Two Companies Restart Virus Trials in U.S. After Safety Pauses

By BY KATHERINE J. WU, CARL ZIMMER, SHARON LAFRANIERE AND NOAH WEILAND from NYT Health AstraZeneca and Johnson & Johnson have restarted their late-stage trials after finding that serious illnesses in a few volunteers appeared not to be related to the vaccines. https://ift.tt/2FVcRmf